Latest Breaking News On - Strides pharma science - Page 1 : comparemela.com

strides pharma science: Stock Radar: This pharma stock sees mild consolidation after 130% rally in 1 year; time to buy the dip?

The pharma stock is a part of the S&P BSE Smallcap index. It saw an uptrend, rising from Rs 393 as of June 9, 2023, to Rs 901 recorded on June 10, 2024. It has, however, undergone mild consolidation of approximately 100 points since April on the daily chart. The stock is in recovery mode with chances of momentum to continue are moderate. Short-term traders can look to accumulate the stock on dips.

Strides pharma science

Q4 results today: Sun Pharma, Grasim, Jubilant, Nykaa, and Ramco Cements among 32 companies to report earnings on May 22

Q4 results on May 22: Petronet LNG, New India Assurance, Metro Brands, Gland Pharma, Sundram Fasteners, Minda Corporation, Gujarat Pipavav Port, HEG, Star Cement, and Indigo Paints, are also among the 32 companies that will announce their Q4 earnings today.

Ashoka buildconSun pharmaGoldiam internationalDhanlaxmi bankMinda corporationGrasim industriesGandhar oil refinery indiaDb corpEverest industriesTeamlease servicesHitachi energyIndia assurance companyKaveri seed companyPi industriesGandhar oil refineryAlso read

Strides Pharma Reports Net Profit Of ₹10 44 Cr In Q4FY24

Total expenses in the fourth quarter were higher at Rs 984.21 crore as compared to Rs 972.26 crore.

Aditya kumarBadree komandurSurabhi loshaliBarun kumarStrides pharma science ltd onBusiness developmentStrides pharma science ltdExecutive chairpersonManaging director arun kumarExecutive director financeStrides pharma scienceVice presidentExecutive directorAvikesh kumarEnd marketsInvestor relations officer

Strides Pharma Records Q4 Profit, Announces Major Leadership Rejig

Strides Pharma Science Ltd reported a consolidated net profit of Rs 10.44 crore for Q4 ending March 2024, reversing a net loss of Rs 13.79 crore a year ago. The company also announced significant top management changes and achieved its highest-ever annual revenue, driven by growth in the US market.

Badree komandurBarun kumarSurabhi loshaliAditya kumarStrides pharma science ltd onBusiness developmentStrides pharma science ltdExecutive chairpersonManaging director arun kumarExecutive director financeStrides pharma scienceVice presidentExecutive directorAvikesh kumarEnd marketsInvestor relations officer

Strides Pharma Consolidated March 2024 Net Sales at Rs 1,084 04 crore, up 9 9% Y-o-Y

Strides Pharma Consolidated March 2024 Net Sales at Rs 1,084 04 crore, up 9 9% Y-o-Y
moneycontrol.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from moneycontrol.com Daily Mail and Mail on Sunday newspapers.

Reported consolidatedStrides pharma scienceNet profit